Miromatrix Medical Inc. (MIRO) Research

Miromatrix Medical Inc. is a life sciences company dedicated to pioneering a novel technology for bioengineering organs that are fully transplantable. Central to its innovative work is a proprietary platform utilizing a two-stage method involving decellularization and recellularization. This sophisticated process entails meticulously removing the native porcine cells from organs harvested from pigs, then introducing unmodified human cells to create viable new structures. Miromatrix maintains significant partnerships with esteemed medical institutions such as The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company, which was originally incorporated in 2009 under the name TayTech, Inc., operates from its headquarters in Eden Prairie, Minnesota.

Market snapshot

Symbol
MIRO
Price
$3.39
Day change
+0.59%
Market cap
$93.0M
P/E ratio
-2.34x
52-week range
0.906-4.35
Sector
Healthcare
Industry
Biotechnology
Analyst price target
$9.00

Peer companies

  • Aadi Bioscience, Inc. (AADI)
  • Berkeley Lights, Inc. (BLI)
  • Cyteir Therapeutics, Inc. (CYT)
  • HilleVax, Inc. (HLVX)
  • IGM Biosciences, Inc. (IGMS)
  • Insight Molecular Diagnostics Inc. (IMDX)
  • Jade Biosciences, Inc. (JBIO)
  • Jounce Therapeutics, Inc. (JNCE)

Recent insider activity

  • UNITED THERAPEUTICS Corp — trade (0 shares) on 2023-12-12
  • Heine Lisa Wipperman — U-Tender (66943 shares) on 2023-12-12
  • Heine Lisa Wipperman — D-Return (67413 shares) on 2023-12-13
  • Maag Peter — U-Tender (62092 shares) on 2023-12-12
  • Maag Peter — D-Return (58368 shares) on 2023-12-13

Open Miromatrix Medical Inc. (MIRO) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.